BRAIN DISEASES AMONG MIDDLE-AGED PEOPLE: SYMPTOMS AND TREATMENT APPROACHES

Аннотация

This article provides a comprehensive analysis of common brain diseases among middle-aged individuals, including their main symptoms, diagnosis, and modern treatment methods. Research shows that neurological disorders are most prevalent in the 40-60 age group. This paper includes detailed scientific and practical information on early detection, prevention, and effective treatment approaches for these diseases. Keywords: brain diseases, neurological disorders, stroke, Parkinson's disease, Alzheimer's disease, migraine, epilepsy, brain aneurysm, diagnosis, treatment, prevention. Аннотация: В данной статье представлен всесторонний анализ распространённых заболеваний мозга у людей среднего возраста, включая их основные симптомы, диагностику и современные методы лечения. Исследования показывают, что наиболее часто неврологические расстройства встречаются в возрастной группе 40-60 лет. В статье содержится детальная научная и практическая информация о раннем выявлении, профилактике и эффективных методах лечения данных заболеваний. Ключевые слова: заболевания мозга, неврологические расстройства, инсульт, болезнь Паркинсона, болезнь Альцгеймера, мигрень, эпилепсия, аневризма мозга, диагностика,лечение,профилактика. Middle-aged individuals are at the peak of their physical and mental activity. However, this stage of life is also associated with the increased risk of developing various pathological conditions. Brain diseases are particularly prevalent among individuals approaching old age, often leading to severe neurological conditions, reduced quality of life, and, in some cases, disability. This article provides an in-depth review of the most common brain diseases in middle-aged individuals, their causes, main symptoms, diagnostic methods, and treatment options.[1] Braindiseases:Stroke Stroke is a serious neurological condition caused by a sudden disruption of blood circulation in the brain. It is classified into two main types: ischemic stroke, resulting from blocked blood vessels leading to oxygen deficiency, and hemorrhagic stroke, caused by the rupture of a cerebral blood vessel and subsequent bleeding. Risk factors include hypertension, atherosclerosis, heart arrhythmias, diabetes, and an unhealthy lifestyle.[8] Symptoms of a stroke include sudden headaches, speech disturbances, facial drooping on oneside, limbparalysis, lossof balance, and unconsciousness. 98,7:ROTCAFTCAPMI.SECNEICS LACIDEM,5202, yraurbeF,5emuloV gro.srehsilbupcimedaca.www Diagnosis is carried out using computed tomography (CT), magnetic resonance imaging (MRI), andlaboratory tests. Treatment for ischemic stroke involves thrombolytic therapy, which dissolves the clot blocking the blood vessel. Hemorrhagic stroke, on the other hand, may require surgical intervention to stopthebleeding. Prevention strategies include blood pressure control, a healthy diet, physical activity, and avoidingharmful habits.[5][7] Parkinson’s disease Parkinson’s disease is a neurodegenerative disorder primarily associated with dopamine deficiency. It develops gradually, affecting movement and coordination. Key symptoms include tremors, bradykinesia (slowed movements), muscle stiffness, and balance impairments. Causes involve genetic predisposition, environmental toxins, and age-related neurodegenerativeprocesses. Diagnosis is based on neurological examinations and MRI scans. Treatment includes dopamine replacement therapy with levodopa, dopamine agonists, physical therapy, and in somecases, deep brain stimulation (DBS)surgery.[3][9] Alzheimer’s disease 98,7:ROTCAFTCAPMI.SECNEICS LACIDEM,5202, yraurbeF,5emuloV gro.srehsilbupcimedaca.www Alzheimer’s disease is a progressive neurodegenerative disorder that leads to memory loss and cognitive decline. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that primarily affects memory, thinking, and behavior. It is the most common cause of dementia and mainly occurs in individuals over 65 years old.The disease gradually worsens, leading to severe cognitivedecline and loss ofindependence. Genetic factors – APOE ε4 gene increases risk; mutations in APP, PSEN1, and PSEN2 causeearly-onset AD. Brain changes – Beta-amyloid plaques and tau tangles disrupt neuron function. Other risks – Aging, cardiovascular diseases, obesity, diabetes, smoking, and head trauma. Symptoms Early stage: Mild memory loss, difficulty concentrating, misplacing objects. Middle stage: Confusion, personality changes, trouble recognizing people. Late stage: Severe cognitive decline, inability to communicate, loss of motor function. Diagnosis :Cognitive tests –MMSE,MoCA. Brain imaging –MRI, CT, PETscans. Biomarkertests –Cerebrospinal fluid analysis. Treatment and Management Medications – Cholinesterase inhibitors (Donepezil, Rivastigmine), NMDA antagonists (Memantine). Newtherapies –Aducanumab targets amyloid plaques Non-drug approaches – Cognitive therapy, exercise, and social engagement. Caregiving – Support for daily activities, specialized